Trial Profile
A Phase 1, Open Label, Randomized, Crossover, Drug Interaction Study of the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride After Separate and Concomitant Administration to Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2012
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 01 Oct 2012 Results published in the Diabetes, Obesity and Metabolism.
- 31 Mar 2010 New trial record